Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers
Taylor LLP are investigating potential claims against the Board of
Directors of Avanir Pharmaceuticals, Inc. (“Avanir”) (NASDAQ:AVNR)
concerning the sale to Otsuka Pharmaceutical Co., Ltd.
for AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Otsuka Pharmaceutical Co., Ltd. investment picks